WCM Investment Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-185,273
Closed -$1.87M 216
2022
Q4
$1.87M Sell
185,273
-2,366
-1% -$44.4K 0.01% 188
2022
Q3
$4.19M Buy
187,639
+9,086
+5% +$263K 0.02% 150
2022
Q2
$4.44M Buy
178,553
+65,173
+57% +$1.8M 0.02% 152
2022
Q1
$4.4M Buy
113,380
+12,452
+12% +$482K 0.01% 152
2021
Q4
$5.91M Buy
100,928
+7,307
+8% +$414K 0.01% 149
2021
Q3
$5.55M Buy
93,621
+501
+0.5% +$39.3K 0.01% 147
2021
Q2
$8.08M Buy
93,120
+3,696
+4% +$298K 0.02% 130
2021
Q1
$7.37M Sell
89,424
-4,765
-5% -$457K 0.02% 128
2020
Q4
$8.56M Sell
94,189
-30,999
-25% -$1.93M 0.02% 125
2020
Q3
$5M Buy
125,188
+7,461
+6% +$261K 0.02% 134
2020
Q2
$4.04M Buy
117,727
+4,253
+4% +$127K 0.02% 137
2020
Q1
$2.52M Buy
113,474
+32,823
+41% +$830K 0.01% 142
2019
Q4
$1.58M Buy
+80,651
New +$1.28M 0.01% 151

Other funds holding FATE